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It is well-established that exposure to emotionally laden events initiates secretion of the
arousal-related hormone epinephrine in the periphery. These neuroendocrine changes
and the subsequent increase in peripheral physiological output play an integral role in
modulating brain systems involved in memory formation. The impermeability of the
blood brain barrier to epinephrine represents an important obstacle in understanding how
peripheral hormones initiate neurochemical changes in the brain that lead to effective
memory formation. This obstacle necessitated the identity of a putative pathway capable
of conveying physiological changes produced by epinephrine to limbic structures that
incorporate arousal and affect related information into memory. A major theme of the
proposed studies is that ascending fibers of the vagus nerve may represent such a
mechanism. This hypothesis was tested by evaluating the contribution of ascending
vagal fibers in modulating memory for responses learned under behavioral conditions
that produce emotional arousal by manipulating appetitive stimuli. A combination of
electrophysiological recording of vagal afferent fibers and in vivo microdialysis was
employed in a second study to simultaneously assess how elevations in peripheral
levels of epinephrine affect vagal nerve discharge and the subsequent potentiation
of norepinephrine release in the basolateral amygdala. The final study used double
immunohistochemistry labeling of c-fos and dopamine beta hydroxylase (DBH), the
enzyme for norepinephrine synthesis to determine if epinephrine administration alone or
stimulation of the vagus nerve at an intensity identical to that which improved memory
in Experiment 1 produces similar patterns of neuronal activity in brain areas involved
in processing memory for emotional events. Findings emerging from this collection of
studies establish the importance of ascending fibers of the vagus nerve as an essential
pathway for conveying the peripheral consequences of physiological arousal on brain
systems that encode new information into memory storage.
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INTRODUCTION
An extensive number of findings reveal that the emotional nature
of learning experiences contributes to the strength that novel
events are encoded and stored into memory. The influence of
highly arousing events on memory is attributed to the impact
salient stimuli have in initiating and maintaining heightened lev-
els of neural activity in the amygdala (Cahill andMcGaugh, 1995;
Gerra et al., 1996; Canli et al., 2002; Chang et al., 2005; Pelletier
et al., 2005). Emotional experiences influence the amydala and
regulate how effective new events are converted into memory by
their capacity to evoke epinephrine secretion from the adrenal
glands (McCarty and Gold, 1981) which in turn initiates a long
lasting and sustained release of norepinephrine in the amyg-
dala (Williams et al., 1998; O’Carroll et al., 1999; Hurlemann
et al., 2005). The contribution of norepinephrine activation of the
amygdala to memory processing is revealed by studies showing
that infusion of this transmitter or beta-noradrenergic agonists
into the basolateral amygdala selectively improve memory for
responses acquired in inhibitory avoidance (Ferry et al., 1999),
contextual fear conditioning (LaLumiere et al., 2003; Huff et al.,
2006), or spatial learning tasks (Hatfield and McGaugh, 1999).
Although a great deal of attention has been devoted to under-
standing how activation of the amygdala modulates neuronal
functioning in other limbic structures during memory forma-
tion, less emphasis has been placed on identifying how changes
in peripheral autonomic activity produced by adrenal hormones,
feedback to the brain to influence noradrenergic activation of the
amygdala during this important process.
Elucidation of the mechanisms underlying these interactions
will provide a more comprehensive understanding of memory
formation since they have circumscribed effects on how effective
new events are represented in memory. For example, the uni-
form enhancement in memory observed following heightened
states of arousal produced by epinephrine release is abolished by
Frontiers in Behavioral Neuroscience www.frontiersin.org June 2012 | Volume 6 | Article 35 | 1
BEHAVIORAL NEUROSCIENCE
Chen and Williams Peripheral and central interactions in memory
experimental manipulations that disrupt amygdala functioning.
Epinephrine’s actions on memory are also ineffective when the
amygdala is lesioned (Cahill and McGaugh, 1991) or if the major
input and output pathways from the amygdala are severed (Liang
et al., 1990; Roozendaal andMcGaugh, 1996). Manipulations that
produce more selective effects on neurotransmitter functioning
such as blocking receptors that bind norepinephrine (Liang et al.,
1986; Quirarte et al., 1997) or depleting amygdala norepinephrine
concentrations with the selective neurotoxin DSP-4 (Liang et al.,
1995) also block the memory enhancing actions of epinephrine.
These two distinct neurochemical changes that follow emotional
arousal have gained a great deal of attention for their role in mod-
ulating memory, however, the pathway that epinephrine secretion
initiates and/or regulates a sustained increase in central nora-
drenergic output is not well understood. Such transmission is
not likely to be a direct process because epinephrine does not
gain access to the CNS due to the restrictive properties of the
blood-brain barrier (BBB) (Weil-Malherbe et al., 1959; Bradbury,
1993).
In light of the restricted access of epinephrine to the brain,
reports from anatomical, electrophysiological, and pharmacolog-
ical experiments suggest that epinephrine’s actions on memory
and in potentiating norepinephrine output in the amygdala may
be mediated by the initial activation of peripheral vagal fibers
that project to the brain. The vagus nerve is considered a poten-
tial candidate to mediate the actions of epinephrine and by
implication, emotional arousal on the brain because dorsal and
ventral branches of the nerve innervate the adrenals (Coupland
et al., 1989), electrical stimulation of the adrenal nerve, which
results in epinephrine release evokes action potentials in the vagus
(Niijima, 1992) and ascending fibers of the vagus are densely
embedded with beta-adrenergic receptors that bind epinephrine
(Schreurs et al., 1986; Lawrence et al., 1995). Blocking periph-
eral beta-adrenergic receptors abolishes arousal-induced changes
in memory, peripheral autonomic functioning or epinephrine
induced increases in vagal nerve firing (van den Buuse et al., 2001;
van den Buuse, 2002; Carrive, 2006; Miyashita and Williams,
2006; King and Williams, 2009). The vagus nerve is also an ideal
candidate to subserve this function because peripheral endings
of the nerve innervate organs such as the heart and lungs that
display heightened activity in humans that show enhanced reten-
tion in response to viewing emotionally arousing slides or animals
displaying similar cognitive improvements following epinephrine
administration (Shapiro and Miselis, 1985; Coupland et al., 1989;
Paton, 1998a,b).
Information regarding changes in the functioning of the
adrenals and other organs after exposure to arousing stimuli are
transmitted via afferent fibers of the vagus nerve (Coupland et al.,
1989; Paton, 1998a,b) to a region of the brainstem known as
the nucleus tractus solitarius (NTS: Kalia and Mesulam, 1980;
Sumal et al., 1983). The projection of vagal afferents to the
NTS is important in understanding how vagal activation may
affect distinct neuronal circuits to regulate norepinephrine release
in the amygdala. For instance, ascending fibers of the vagus
synapse on the A2 norepineprhine-containing neurons in the
NTS (Sumal et al., 1983) that course through the brainstem to
innervate and release norepinephrine in the amygdala (Fallon
et al., 1978; Bjorklund and Lindvall, 1986; Riche et al., 1990;
Petrov et al., 1993). A2 neurons in the NTS also project directly
to locus coeruleus neurons (LC; Van Bockstaele et al., 1999) that
provide the major source of noradrenergic innervation to the
basolateral amygdala (Fallon et al., 1978). Interestingly, electri-
cal stimulation of ascending vagal fibers or epinephrine injection
alone, produces significant and long lasting increases in amyg-
dala norepinephrine levels that are attenuated by inactivating the
site of termination of vagal axons in the brainstem, the NTS
(Williams et al., 1998, 2000; Hassert et al., 2004). Thus, vagal
activation in response to epinephrine secretion may represent
one mechanism by which emotionally arousing events facilitate
memory processing by initiating norepinephrine release in the
amygdala.
However, no findings to date have demonstrated simultane-
ously, that vagal nerve firing consequent to elevations in periph-
eral epinephrine levels, influence noradrenergic functioning in
the amygdala to facilitate memory processing. The following
studies were conducted to address this shortcoming with three
separate approaches. These experiments examined this hypothe-
sis by first determining if stimulating vagal afferent fibers at an
intensity that augments norepinephrine release in the amygdala
(Hassert et al., 2004), enhances memory for responses learned
under behavioral conditions that produce emotional arousal by
manipulating appetitive stimuli as opposed to administering nox-
ious stimuli such as footshock. A second study utilized electro-
physiological recording of vagal afferent fibers in conjunction
with in vivomicrodialysis to assess simultaneously, how elevations
in peripheral levels of epinephrine affect vagal nerve discharge
and the subsequent potentiation of norepinephrine release in
the basolateral amygdala. The final study used double immuno-
histochemistry labeling of c-fos and dopamine beta hydroxylase
(DBH), the enzyme for norepinephrine synthesis to determine
if epinephrine administration alone or stimulation of the vagus
nerve in separate groups of subjects produce similar patterns of
neuronal activity in brain areas that process memory for emo-
tional events. Findings emerging from this collection of studies
are expected to reveal the contribution of ascending fibers of
the vagus nerve in serving as an essential pathway for convey-
ing the peripheral consequences of emotional arousal induced by
epinephrine secretion on brain systems that encode new experi-
ences into memory storage.
EXPERIMENT 1
The objectives of the first experiment were two-fold. This study
determined if reducing the quantity of expected rewards pro-
duces emotional changes associated with frustration (i.e., the
“Crespi Effect”) that are manifested by decreases in motiva-
tion and behavioral responding. These changes are indexed by
increased latencies to run the length of the runway to receive the
reduced quantity of food rewards. The second goal was to deter-
mine whether retention of the emotional experience involving
reward reduction is improved by increasing noradrenergic drive
within the amygdala by post-training stimulation of vagal afferent
fibers with an intensity that has been shown to produce signifi-
cant and long lasting elevations in norepinephrine release in this
structure.
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METHODS
SUBJECTS
Twenty-three male Sprague-Dawley rats (275–300 g) obtained
from Charles River Laboratories (Wilmington, MA) were used in
Experiment 1. The rats were individually housed in polypropy-
lene cages with corncob bedding and maintained on a standard
12:12 h light–dark cycle with lights on at 7:00 a.m. Food and water
were available ad libitum during the seven day adaptation period
to the vivarium.
SURGERY TO IMPLANT VAGAL STIMULATION ELECTRODES
Atropine sulfate (0.4mg/kg) was given ip 10min before anesthesia
with sodium pentobarbital (50mg/kg). Each rat was implanted
with a stimulating electrode on the left vagus nerve at the cervical
level that was constructed from two 30-gauge, 7 cm long insu-
lated silver wires, stripped 1mm on one end (the electrode end),
and 1mm on the other end (the current source end). As shown
in Figure 1, polyvinyl chloride (PVC) tubes were placed over the
7mm exposed section of each wire and contact was achieved by
forming the electrode into a helix that, when implanted, would
encircle the nerve. The two wires were inserted into a 3.5 cm
piece of PVC and the electrode was completed by soldering metal
female pins to the 1mm stripped leads. The electrode leads from
the vagus nerve were then drawn under the skin through the
neck to the dorsal surface just posterior to the skull and affixed
to a head post constructed from an Amphenol miniature strip
connector and cemented to the skull with dental acrylic. The
male pins were later attached to the female pins via 30 gauge sil-
ver wires to deliver electrical stimulation supplied by a current
generator (Model 82400, Lafeyette Instruments, Lafeyette, IN).
Electrode placement along the vagus was verified visually and
by monitoring resistance between the two stimulating electrodes
with a digital voltmeter. The resistance was constantly monitored
to ensure the effectiveness of the vagus nerve stimulation (VNS).
STRAIGHT ALLEY FOOD REWARD TASK
Apparatus
As shown in Figure 1, the training apparatus consisted of a
72-inch long straight alley that was 15 inches in height, 10 inches
wide and constructed of wood. The apparatus included a start
compartment ( 6 inches long) that was blocked by a sliding door
connected to a digital timer. The alley also included three hurdles
(5 cm high) that were placed 2, 12, and 24 inches from the start
box to ensure that a standard level of effort and motivation devel-
ops to obtain the food rewards. The goal cup containing the food
rewards was 1 inch wide and placed at the end of the alley.
Training
Rats were placed on a weight maintenance schedule seven days
before training to reduce weights to 15% below ad-lib feeding
weights. Each animal was pre-exposed for two days to sucrose
pellets (45mg; Research Diets, Inc, New Brunswick, NJ) used for
rewards throughout the study. Animals were randomly assigned
to groups that would be given either sham or vagal stimulation
following a shift or reduction in food reward from the normally
expected 10 pellets to a small reward of only one sucrose pellet on
Day 24. Training began by placing each rat in the start box fac-
ing away from the closed sliding door. The door was opened and
the rat was given 120 s to jump over the three hurdles to reach
and consume the sucrose pellet rewards placed in the food cup
at the end of the six-foot long alley. As soon as the reward was
consumed, the trial ended and the rat was placed in a holding
FIGURE 1 | Time line for the training and testing regimen in the straight alley learning task and dimensions of the training apparatus. Illustration of
the electrode implanted along the vagus nerve to produce vagal nerve stimulation.
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cage for an inter-trial interval (ITI) of 30 s. The latency to con-
sume the food reward was measured on each of the four daily
trials using a digital timer. The animals were trained onDays 1–11
prior to surgery (Figure 2A) to implant the vagal stimulating elec-
trode. They were then given seven days of postoperative recovery
(Days 12–18) before training resumed on Day 19 and continued
for 5 days (See Figure 1 for timeline).
Induction of emotional frustration by shifting reward magnitude
The experimental or “Shift” day in which emotional frustration
was produced by the reduction in reward magnitude from 10 to 1
food pellets occurred on Day 24. On this day, animals assigned to
the “No-Shift” group continued to receive 10 pellets while those
in the “Shift Group” received only one, rather than 10 pellets on 6,
as opposed to the normal four daily training trials. Each rat was
removed from the alley after the sixth trial and those in the vagus
nerve stimulation group received three, 10 s stimulations (0.4mA
current separated by 10 s intervals) along the left cervical vagus.
The stimulation parameters were selected from those previously
shown to produce long lasting elevations in amygdala concentra-
tions of norepinephrine (Hassert et al., 2004) after VNS. Animals
in the sham groups received no stimulation but were connected
to the stimulating device. The four groups in Experiment 1 con-
sisted of a Sham-No Shift (Sham-NS), VNS-No Shift (VNS-NS),
Sham-Shift, and VNS-Shift. The subjects remained on the weight
maintenance schedule and were not disturbed during the seven
day interval between shift in rewardmagnitude and the first reten-
tion test (Days 24–31). This extended delay interval was imposed
to examine whether memory of the frustrating experience of
reward reduction is encoded more effectively by activating the
vagus nerve following training since retention for this type of
change in reward contingency decays in control animals after
FIGURE 2 | The runway latencies of each training group during
pre-surgical training (A), post-surgical training (B) and during the three
days of retention testing (C). There were no significant differences
between groups during the training periods. The reduction in reward
magnitude from 10 pellets to only 1 pellet on the day of the Shift resulted in
significantly longer latencies in the two shifted groups (Sham-Shift and
VNS-Shift) relative to the Non-Shifted controls (Sham-NS and VNS-NS).
The VNS-Shift group received vagal stimulation after the six training trials
with the reduced reward whereas the Sham-Shift group was connected to
the stimulator but no current was applied. Retention for the frustrating
experience of reward reduction produced by the Shift was assessed
one-week later on three daily retention tests. Animals in the vagal
stimulation Shift group displayed enhanced retention on the 7 day delayed
retention test as evidenced by their continued long latencies to traverse
the maze to consume the reduced reward of 1 pellet. Details included in
the text.
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a one-week delay but remains intact in groups administered
memory modulating treatments (Salinas et al., 1996).
Retention test
During the three days of retention testing (Days 31–33), ani-
mals in the shifted groups continued to receive a 1 pellet food
reward on each of the six retention trials while those in the non-
shift groups received the standard 10 pellets upon reaching the
goal box. The latency to run the length of the alley and cross the
three hurdles to consume the 10 pellets (non-shift groups) or the
reduced quantity of one pellet (shifted groups) was recorded and
served as an index of memory for the reduction in food reward.
Statistical analysis
Behavioral measures from the straight alley task are expressed
as mean ± SE. A One-Way analysis of variance (ANOVA) fol-
lowed by post hoc tests were used to detect differences in the
latency to consume the food rewards between Shifted Sham and
VNS groups as well as the No-Shift controls. Repeated measure
ANOVA’s were used to analyze differences in the latency to con-
sume the reward between treatment groups during the training
days, the shift day, and the first trial of the retention test.
RESULTS
EFFECTS OF REDUCING THE MAGNITUDE OF EXPECTED REWARDS
As depicted in Figure 2B, performance was statistically similar
in all groups during the 5 days of post-operative training that
preceded the shift in reward magnitude on Day 24. On this day
however, decreasing the expected value in reward from 10 to only
1 pellet caused a significant overall change in the runway perfor-
mance of the shifted groups as revealed by a One-Way ANOVA
F(3, 19) = 9.137, p < 0.01. F(3, 21) = 8.44, p < 0.01. As shown in
(Figure 2B), Post-hoc analysis revealed that the two shifted groups
took significantly longer to cross the three hurdles and run the
length of the six foot long alley to consume the new quantity
of one reward pellet compared to the two non-shifted groups
(Sham-Shift vs. Sham—NS, p < 0.01; Sham-Shift vs. VNS-NS,
p < 0.01; VNS-Shift vs. Sham-NS, p < 0.01; VNS-Shift vs. VNS-
NS, p < 0.01). These findings demonstrate the procedures used
to induce emotional frustration through reward reduction pro-
duce reliable changes in behavior that are reflected in increased
latencies and lower motivational levels to approach and consume
the food rewards.
EFFECTS OF VNS ON LONG TERM RETENTION
A comparison of the mean runway latencies recorded during the
six daily trials on the three days of retention testing is shown in
Figure 2C. Post-training VNS produced a significant enhance-
ment in memory for reward reduction on the first retention
test given 7 days after the Shift. A One-Way ANOVA revealed
a significant group difference [F(3, 19) = 9.575; p < 0.01]. Post-
hoc comparisons with Fisher’s PLSD tests showed that the run-
way latencies of the VNS-shifted group were significantly longer
than both non-shifted groups (VNS-Shift vs Sham-NS, p <
0.01; VNS-Shift vs. VNS-NS, p < 0.01) as well as the Sham-
Shift group that also experienced a reward reduction (p < 0.01).
The lasting consequences of reward reduction were evident on
each of the three retention tests given on Days 31–33. A One-
Way ANOVA on retention day 2 [F(3, 19) = 9.613; p < 0.01]
and 3 [F(3, 19) = 7.172, p < 0.01] revealed that both the shifted
groups exhibited longer latencies to consume the reward than
the unshifted groups (Sham-Shift vs. Sham- NS, p < 0.01; Sham-
Shift vs. VNS-NS, p < 0.01; VNS-Shift vs. Sham-NS, p < 0.01;
VNS-Shift vs. VNS-NS, p < 0.01). The results demonstrate that
increasing neural transmission from the vagus to the brain fol-
lowing an emotional event enhances memory and these effects
are evident even when assessments of retention are delayed for as
long as 7 days after the experience.
EXPERIMENT 2
Our previous findings demonstrated that neural activity recorded
along the cervical vagus increased significantly following
epinephrine injection and these excitatory actions were not
observed in groups given an identical dose of the hormone after
peripheral β-adrenergic receptor blockadewith sotalol (Miyashita
and Williams, 2006). These findings demonstrate that neural dis-
charge in vagal afferent fibers is increased by elevations in periph-
eral concentrations of epinephrine and the effects are mediated in
part by epinephrine binding to peripheral β-adrenergic receptors
along the vagus nerve. This study also revealed the time course the
nerve maintains high levels of firing following epinephrine coin-
cides with the time course norepinephrine levels in the amygdala
remain elevated after an identical dose epinephrine (Williams
et al., 1998, 2000) or following stimulation of the vagus nerve at
an intensity that improves memory (Hassert et al., 2004). When
considered together, these findings raise a fundamental question
as to whether neural impulses propagated along the vagus fol-
lowing emotional arousal and/or epinephrine secretion serve an
important function in maintaining high-levels of noradrenergic
transmission in the brain during the period of memory consoli-
dation. However, no study to date has examined simultaneously,
whether elevations in peripheral levels of epinephrine that lead to
increased firing along ascending fibers of the vagus nerve, par-
allel the sustained changes in norepinephrine output that are
observed in the amygdala. The present study combined elec-
trophysiological and in vivo microdialysis approaches that were
employed separately in the studies discussed above, to specifi-
cally test whether heightened activity in ascending vagal fibers
following epinephrine administration regulates the release of
norepinephrine in the amygdala.
METHODS
SUBJECTS
Forty-four male Sprague-Dawley rats purchased from Harlan
Laboratories weighing approximately 250–300 g were used in this
study. They were singly housed and maintained on a 12-h light-
dark cycle (lights on at 6:00 a.m.) with water and food available
ad libitum. The rats were handled daily for one week prior to the
initiation of all experiments.
SURGERY
Two separate surgical procedures were performed in one-stage.
The first involved severing the efferent rootlets of the left vagus
nerve at the level of the cervix. This procedure was crucial
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to insure that electrophysiological recordings in response to
epinephrine administration derived solely from the intact ascend-
ing branches of the nerve and did not reflect impulses prop-
agated along the cut descending fibers. The second procedure
involved stereotaxic implantation of a microdialysis guide can-
nula above the left basolateral amygdala to measure extracellular
concentrations of norepinephrine in response to epinephrine-
induced changes in vagal nerve firing. The methods used to
severe the efferent branch of the vagus nerve was adopted and
modified from those of Norgren and Smith (1994). Each rat
was anesthetized with an intramuscular injection of ketamine
(100mg/kg). A 3–4 cm incision was made from the chin to the
thorax and the salivary gland, and lymph nodes were retracted
laterally to expose the sternohyoid and omohyoid muscles. These
two muscles were then separated from the underlying muscles
to expose the superior laryngeal nerve and thyroid artery. A #15
blade in a scalpel handle was used to create an opening in the
occipital bone to expose the efferent rootlets of the vagus nerve.
The efferent rootlets were severed using ultra-fine forceps and the
cavity was packed with bone wax. The retracted muscles, salivary
gland, lymph nodes, and skin were repositioned and the skin was
closed with suture.
Following deafferentation, each rat was placed in a stereotaxic
apparatus and a midline incision on the skull was made to expose
bregma. A single microdialysis guide cannula was lowered 2mm
above the basolateral amygdala (AP −3.0, L +5.0, DV −6.7)
according to the atlas of Paxinos and Watson (1986). Following
implantation, the guide cannula was cemented to the skull by two
anchoring screws using dental acrylic. Animals were then allowed
seven days to recover from both surgeries prior to electrophysio-
logical recordings combined with in vivo microdialysis collection
of norepinephrine.
Simultaneous vagal recording and microdialysis sample collection
On the experiment day, the rat was anesthetized with urethane
(1.2 g/kg, i.p.) and a 4 cm incision was made 5mm lateral to of
the midline of the cervix to identify the internal carotid artery
and cervical branch of the vagus nerve. Approximately 1 cm of
the nerve was separated from connective tissue and placed onto
two 30 gauge silver wire hook electrodes connected to a recording
device. After the surgical preparation and recording settings were
established, a 1:1 petroleum jelly and mineral oil mixture was
used to cover the vagus nerve and electrodes, preventing dryness
and the interference of tissue fluids during recording. The ani-
mal was left undisturbed for a 45min period of nerve stabilization
before any recordings were measured.
During recording, multifiber neural activity in the form of
mV was collected from the electrodes, amplified 10–20,000 times
using AC amplifiers (Grass, P511; Astromed: West Warwick, RI)
with low (100Hz) and high (1 kHz) frequency cutoffs. The sig-
nals were relayed to a spike processor to separate signals gener-
ated from action potentials from those with variable amplitudes
derived from background noise. The window discriminator was
set above the level of noise on a computer screen and the output
of the spike processor representing action potentials from only the
nerve fiber were averaged using the Chart data acquisition soft-
ware (ADI instrument: Mountain view, CA) and monitored with
an audio amplifier. For data analysis, the amplified signals were
passed through an integrator with a time constant of 1 s and the
summated electrical activity from action potentials recorded from
the whole-nerve was stored on a PC computer and analyzed with
the Chart program.
Concomitant microdialysis collection and electrophysiological
recording from the vagus nerve
During the first hour pre-collection period, a microdialysis probe
(CMA/12; Carnegie /Medicin, Acton, MA) was inserted into the
left basolateral amygdala. After the vagal surgical procedures were
carried out, the rat was left undisturbed until the pre-collection
period was over. During this period, no brain samples or nerve
activity was recorded. At the start of the second hour, dialysate
samples of norepinephrine were collected every 20min over a
period of 60min. The concentration of norepinephrine in these
three samples was averaged to represent baseline levels of this
transmitter in the amygdala. Electrical recordings of vagal basal
activity were initiated during the final 30min of this period and
consisted of 15 minutes of baseline collection that was followed
by i.p. injection of saline or sotalol to block peripheral adrenergic
receptors in some groups and a second period of 15min of collec-
tion to ensure the drug injections alone, did not affect vagal nerve
firing.
The rats were randomly assigned to one of seven treatment
groups. Four of these groups received an ip injection 15min
prior to the start of the experiment of either saline, 4.0mg/kg
of the peripherally acting beta-adrenergic antagonist Sotalol or
2.0mg/kg of this antagonist (two groups). These groups would
also be given an ip injection at the very beginning of the exper-
iment at time period (0) of saline or epinephrine. This com-
bination of treatments resulted in the following four groups
(SAL, n = 7); sotalol 2.0mg/kg + saline (SOT2 + SAL, n =
6); sotalol 4.0mg/kg + saline (SOT4 + SAL, n = 4); sotalol
2.0mg/kg + epinephrine 0.3mg/kg (SOT2 + EPI, n = 4). Three
additional groups received initial injections of 0.3mg/kg of
epinephrine at time period (0) and a second injection of 2.0
or 4.0mg/kg of sotalol that was delayed by 60min. These
groups were included to determine whether blocking periph-
eral adrenergic receptors after vagal firing had reached asymptote
attenuates neural impulses recorded from the vagus nerve. The
groups consisted of epinephrine 0.3mg/kg alone (EPI, n = 6);
epinephrine 0.3mg/kg + sotalol 2.0mg/kg (EPI + SOT2, n = 6);
and epinephrine 0.3mg/kg + sotalol 4.0mg/kg (EPI + SOT4,
n = 6). The recording period lasted for 3 h after the first injection.
Norepinephrine assay with HPLC
Dialysate samples (35 ul) of norepinephrine were assayed by an
HPLC system with a Waters 510 pump, Waters 717 autosam-
pler, Atlantis T3 column (3 micron ODS, 4.6 × 100mm) and a
Waters 2465 electrochemical detector. Themobile phase consisted
of 50mg disodium EDTA, 13.8mgmonobasic sodium phosphate,
and 58mg octane sulfonate adjusted to pH 3.2 by adding 85%
phosphoric acid. The flow rate was adjusted to 1.0ml per minute.
Histology
The rat was deeply anesthetized with Euthosol (Virbac) and per-
fused with 0.9% saline and 10% buffered Formalin intracardially.
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The perfused brains were stored in 10% buffered Formalin, sec-
tioned at the thickness of 50 um using a Vibratome, mounted
onto gelatin-coated slides, stained with cresyl violet, coverslipped,
and then dried. The cannula tracts were verified using a micro-
scope Olympus CX41. Three animals were excluded from the
study due to incorrect cannula placement and electrophysio-
logical data from two animals were discarded due to technical
problems. This yielded 6, 6, 6, 7, 4, 4, and 6 animals in the
EPI, EPI + SOT2, EPI + SOT4, SAL, SAL + SOT4, SOT2 +
EPI, and SOT2+ SAL groups respectively for electrophysiological
recording.
Statistical analysis
Electrophysiology. Two separate sets of analyses were performed
to characterize the data collected from the vagal recording.
Repeated measure and factorial ANOVAs were used respec-
tively, to assess fluctuations in vagal neural activity across and
within treatment groups during the 15min drug free base-
line period. Data points in the analysis were taken by averag-
ing electrical activity of the vagus nerve in millivolts in 5min
bins. Any change in electrical activity measured in each sub-
sequent 5min bin during the 15min drug free baseline period
is expressed as the percentage change relative to this value.
A repeated measure ANOVA was used to detect changes in
whole nerve neural activity across the 180min collection period.
Factorial ANOVA’s with post-hoc Fisher’s tests were used to
detect differences between individual treatment groups (i.e., SAL,
SOT2 + SAL, SOT2 + EPI, EPI, SAL + SOT4, EPI + SOT2
EPI + SOT4). A level of p < 0.05 was deemed significant in all
analysis.
In vivo microdialysis. The levels of norepinephrine (in pico-
grams per microliter) collected from the basolateral amygdala
during the initial 60min baseline period was averaged to yield
a standard baseline value of 100%. The concentration of nore-
pinephrine collected from dialysate samples throughout the
experiment is expressed as the percent change above or below the
baseline value. A Two-WayANOVAwas used to evaluate the over-
all effect of treatment for each group relative to baseline levels.
This resulted in a mixed factorial analysis with one between-
subjects factor (treatments), one within-subjects factor (time),
and one interaction (Treatments × Time).
RESULTS
VAGAL RECORDING
Baseline comparisons
There were no between group differences in vagal neural activ-
ity during the 15min baseline period or the 15min period that
followed saline or sotalol injection. This tendency was consistent
within and across each of the experimental groups. A Two-Way
repeated measure ANOVA for changes in vagal neural acitivity
during the 15min drug free baseline period revealed no sig-
nificant overall effects for treatment [F(6, 32) = 0.37, p = 0.89]
or time [F(2, 64) = 1.42, p = 0.24] or interaction between time
and treatment [F(12, 64) = 0.36, p = 0.97]. Additional factorial
ANOVAs used to detect overall differences in neural activity
between the seven treatment groups during each of the three
5min bins following saline or sotalol administration also yielded
no significant effects.
Post-injection within group comparisons
Figure 3 shows that over the 3 h recording period following drug
treatment, groups given epinephrine injection at time period
(0) and sotalol 60min later (i.e., EPI, EPI + SOT2, and EPI +
SOT4) exhibited increases in vagal firing discharge that remained
statistically significant above baseline during the 10–60min post-
epinephrine injection. For the remaining time of recording, vagal
activity in the EPI and EPI + SOT2 groups gradually decreased to
approximately 20% above the valuesmeasured at baseline. In con-
trast, vagal activity in the EPI + SOT4 group dropped steeply at
minute 90 (sotalol was given at 60min after epinephrine injection),
and was reduced by 50% relative to baseline at the end of record-
ing. In addition, neural activity recorded from the vagus nerve in
the SAL, SAL + SOT4, SOT2 + EPI, and SOT2 + SAL groups
showed a tendency to decrease over time with a reduction rate
of 50% relative to baseline at the end. A Two-Way repeated mea-
sure ANOVA indicated that drug treatment caused a main group
difference [F(6, 32) = 10.21, p < 0.0001]. Additionally, time was
another factor that contributed to the overall change in vagal
neural activity [F(19, 608) = 42.28, p < 0.0001]. An interaction
between treatment drug and time was also observed [F(114, 608) =
2.47, p < 0.0001].
Individual repeated measure ANOVAs comparing baseline lev-
els of vagal activity with that occurring during the post-injection
period also revealed significant differences across time in all seven
treatment groups [EPI: F(5, 19) = 7.9, p < 0.0001, EPI + SOT2:
F(5, 19) = 3.6, p < 0.0001, EPI + SOT4: F(5, 19) = 18.2, p <
0.0001, SAL: F(6, 19) = 5.9, p < 0.0001, SOT2 + SAL: F(5, 19) =
8.3, p < 0.0001, SAL + SOT4: F(3, 19) = 5.1, p < 0.0001, and
SOT2 + EPI: F(3, 19) = 13.0, p < 0.0001]. With the exception of
the EPI, EPI + SOT2, and EPI + SOT4 groups, the significant
changes identified in this analysis were attributed to reductions in
neural activity recorded from this preparation during the 180min
post-injection period relative to baseline levels. In contrast, post-
hoc analysis revealed that neural activity recorded from the vagus
of animals given EPI, EPI + SOT2, EPI + SOT4 increased signifi-
cantly above baseline values 10min post-injection (p < 0.05) and
remained significantly elevated for each of the next five periods of
data collection (i.e., from 10 to 60min).
Between group comparisons
From 10 to 60min post epinephrine injection, neural activity
along vagal ascending fibers were significantly higher in the EPI,
EPI + SOT2, and EPI + SOT4 groups than any of the SAL,
SOT2 + SAL, SOT2 + EPI, and SAL + SOT4 groups. A facto-
rial ANOVA with post-hoc Fisher’s tests run at each post-injection
data collection point revealed significantly higher levels of vagal
activity in the EPI, EPI + SOT2, EPI + SOT4 relative to groups
treated with SAL, SOT2 + SAL, SOT2 + EPI, or SAL + SOT4
at each of the data collection points 10–60minutes post-injection
[10min: F(6, 32) = 8.01, p < 0.0001; 20min: F(6, 32) = 8.11, p <
0.0001; 30min: F(6, 32) = 9.43, p < 0.0001; 40min: F(6, 32) =
12.70, p < 0.0001; 50min: F(6, 32) = 11.32, p < 0.0001; 60min:
F(6, 32) = 9.58, p < 0.0001; for post-hoc comparisons between
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FIGURE 3 | The effects of systemically administered saline, epinephrine
(0.3mg/kg), sotalol (2.0 or 4.0mg/kg) or the combination of epinephrine
and sotalol on vagal nerve firing in Millivolts. Animals received sotalol
15min prior to minute (0) and epinephrine at this time point. The first
injection at 0min. Two of the epinephrine injected groups received a second
injection at 60min that consisted of sotalol at 2mg/kg or 4mg/kg. One of the
saline injected groups received a second injection at 60min of sotalol at
4mg/kg. The EPI, EPI + SOT2, and EPI + SOT4 groups exhibited significant
increases in vagal firing discharge above baseline for 10–60min
post-epinephrine injection. For the remaining time of recording, vagal activity
in the EPI and EPI + SOT2 groups gradually decreased to approximately 20%
above basal values. In contrast, vagal activity in the EPI + SOT4 group
dropped steeply at 40min post-sotalol injectionand was reduced by
approximately 50% relative to baseline at the end of recording. Neural
activity recorded in the form of Millivolts from the vagus nerve in the SAL,
SAL + SOT4, SOT2 + EPI, and SOT2 + SAL groups decreased
over time with a reduction of approximately 50% relative to baseline
at the end.
any of EPI, EPI + SOT2, and EPI + SOT4 groups vs. any of SAL,
SOT2 + SAL, SOT2 + EPI, and SAL + SOT4 groups, p-values <
0.05].
Factorial ANOVAs at 80–150min post-injection continued to
reveal significant overall differences between treatment groups.
Post-hoc tests indicated that during this period, the EPI group
continued to show a significantly higher-level of vagal activity
than any of the SAL, SOT2+ SAL, SOT2+ EPI, and SAL+ SOT4
groups (p < 0.05). During 110–150min post-injection, vagal dis-
charge of the EPI group remained higher than the SAL, SOT2 +
SAL, SOT2 + EPI, and SAL + SOT4 groups (p < 0.1). For
the remaining recording period (i.e., 160–180min), vagal activ-
ity in the EPI group was not different from any of the control
groups.
During 70–80min post epinephrine injection, vagal activity of
the EPI + SOT4 group was not different from the EPI and EPI +
SOT2 groups. During 90–150min post-epinephrine injection, the
EPI + SOT4 group showed significantly lower vagal activity com-
pared to the EPI group (EPI vs. EPI + SOT4, p < 0.05). During
90–180min post-epinephrine injection, the EPI + SOT4 exhib-
ited a level of vagal activity that was not different from that of any
of the control groups, i.e., SAL, SOT2 + SAL, SOT2 + EPI, and
SAL + SOT4 (p > 0.1).
Norepinephrine release in the basolateral amygdala
Baseline comparisons. As shown in Figure 4, the baseline levels
of norepinephrine were similar across treatment groups during
the 60min drug free baseline period. A Two-Way repeated mea-
sure ANOVA for changes in norepinephrine release for the 60min
baseline period showed no main effect by group [F(6, 31) = 0.1,
p = 0.99], time [F(2, 62) = 0.4, p = 0.66], or their interaction
[F(12, 62) = 0.3, p = 0.99]. Individual factorial ANOVAs at each
baseline collection point did not detect any significant group
effect during the drug free period.
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FIGURE 4 | The effects of systemically administered saline, epinephrine
(0.3mg/kg), sotalol (2.0 or 4.0mg/kg), or the combination of
epinephrine and sotalol on norepinephrine release in the amygdala.
Basal levels of norepinephrine were similar across treatment groups during
the 60min drug-free baseline period. Norepinephrine concentrations sampled
from the amygdala of the EPI and EPI + SOT2 groups showed consistent and
sustained increases throughout the collection period whereas the
norepinephrine levels of EPI + SOT4 became comparable to
control groups at 180min post-epinephrine injection. Blocking
peripheral beta-adrenergic receptors with sotalol blocked
epinephrine induced augmentation of norepinephrine output in the
amygdala.
Post-injection comparaisons. During the 3 h post-epinephrine
collection period, norepinephrine levels in the basolateral
amygdala fluctuated differently depending upon a given drug
treatment. Norepinephrine concentrations sampled from the
amygdala of the EPI, EPI+ SOT2 and EPI+ SOT4 groups showed
significantly consistent and sustained increases throughout the
collection period whereas the levels sampled from the control
groups, (i.e., SAL, SOT2 + SAL, SOT2 + EPI, and SAL + SOT4)
showed reductions over time that were approximately 40% lower
than the baseline values. A Two-Way repeated measure ANOVA
comparing norepinephrine levels over the 180min duration indi-
cated significant differences between the seven treatment groups
[F(6, 31) = 9.65, p < 0.0001] as well as an interaction between
treatment and time [F(54, 279) = 3.1, p < 0.0001].
Individual repeated measure ANOVAs comparing nore-
pinephrine levels at each post-injection collection time point
with baseline values detected that there were increases of nore-
pinephrine release over time in the EPI, EPI + SOT2, and EPI +
SOT4 groups but decreases over time in the SAL, SOT2 + SAL,
SOT2 + EPI, and SAL + SOT4 groups [EPI: F(9, 45) = 3.9, p <
0.001; EPI + SOT2: F(9, 36) = 3.0, p < 0.01; SAL: F(9, 54) = 8.6,
p < 0.0001; SOT2 + EPI: F(9, 45) = 3.90, p < 0.01; SOT2 + SAL:
F(9, 27) = 2.4 < 0.05; SAL + SOT4: F(9, 27) = 3.8, p < 0.01].
Post-hoc analysis revealed that norepinephrine release in the EPI,
and EPI+ SOT2 groups increased significantly above initial base-
line values at 20min post-injection (p < 0.05) and remained
significantly elevated for each of the following eight periods of
data collection (i.e., from 40 to 180min) (p < 0.05). In addition,
significant changes identified in the SAL, SOT2 + SAL, SOT2 +
EPI, and SAL + SOT4 groups were attributed to reductions in
norepinephrine release during the 180min post-injection period
relative to baseline levels.
Between group comparison. Factorial ANOVAs detected group
difference at each collection time point after epinephrine injec-
tion. Post-hoc tests comparing the EPI groups with the controls
groups at each post-epinephrine collection point, revealed that
levels of norepinephrine sampled from the amygdala were sig-
nificantly higher than those of the SAL, SOT2 + SAL, SOT2 +
EPI, and SAL + SOT4 groups (all p-values < 0.05). The EPI
+ SOT2 groups showed significantly higher levels of amyg-
dala norepinephrine than any control groups over the 180min
post-epinephrine injection (i.e., p < 0.05) vs. SAL, SOT2 +
SAL, SOT2 + EPI, and SAL + SOT4. The EPI + SOT4 group
Frontiers in Behavioral Neuroscience www.frontiersin.org June 2012 | Volume 6 | Article 35 | 9
, p
Chen and Williams Peripheral and central interactions in memory
exhibited significantly higher norepinephrine levels up to 140min
post-epinephrine injection and then declined for the remaining
two periods of collection. At 180min post-injection, the nore-
pinephrine levels of the EPI + SOT4 group were significantly
lower than those of the EPI and EPI + SOT2 groups. Post-
hoc tests comparing the EPI + SOT4 with other groups at each
post-epinephrine collection point, revealed that the levels of nore-
pinephrine release in the amygdala was significantly higher than
the SAL, SOT2+ SAL, SOT2+ EPI, and SAL+ SOT4 groups dur-
ing 40–140min post-epinephrine injection (all p-values < 0.05).
After 160 minutes, norepinephrine levels in the EPI + SOT4
group declined and was not different from any of the control
groups (p = 0.11). Post-hoc tests revealed no significant differ-
ence in norepinephrine levels between any control group at each
of the 180min time periods. Additionally, norepinephrine release
in these groups was reduced by approximately 40% at the end of
collection.
EXPERIMENT 3
The capacity for emotionally arousing events to affect central
structures that process memory may require the integration of
peripheral epinephrine secretion, vagal neural transmission, acti-
vation of noradrenergic neurons in the brainstem, and noradren-
ergic release in important limbic structures. The current study
will identify which components of this system are influenced
by the two mechanisms that are known to be the peripheral
substrates (i.e., increased epinephrine levels and vagal firing dis-
charge) of an arousal related system that is involved in the modu-
lation of memory. The patterns of activation induced by either
epinephrine administration or VNS will be assessed using Fos
immunocytochemistry. Additionally, activation of noradrenergic
cells will be examined using Fos coupled with DBH immunocy-
tochemistry. The immediate early gene c-fos is known to play a
role in transcriptional regulation that leads to molecular changes
for hours to days (Chiasson et al., 1997). At cellular levels,
the expression of Fos protein is rapidly induced by the activity
of neurotransmitters or neuromodulators, and electrical excita-
tion at the cell surface (Morgan and Curran, 1986). Therefore,
the detection of Fos protein is often used as a neuronal maker
to label cells with activity changes in response to exogenous
stimuli.
Findings from the current study will reveal whether or not
increased levels of epinephrine and VNS produce similar pat-
terns of neuronal activation within memory associated areas
of the brain. Furthermore, localization of activated noradren-
ergic neurons with those that express Fos protein will reveal
the contribution of noradrenergic nuclei in driving limbic areas
that respond to peripheral physiological arousal. The current
study would be the first to provide a comprehensive assessment
on activation patterns in memory associated structures induced
by different peripheral arousal mechanisms. If the patterns of
activation following the two treatments are convergent, the find-
ings will suggest that up-regulated peripheral adrenergic activ-
ity induced by emotional arousal increases neural transmission
along ascending vagal fibers that in turn, generates cellular activ-
ity within central noradrenergic systems that modulate memory
formation.
METHODS
SUBJECTS
Thirty-one male Sprague-Dawley rats purchased from Charles
River Laboratories weighing approximately 250–300 g were used
in this study. They were singly housed, and maintained on a
12-h light–dark cycle (lights on at 6:00 a.m.) with water and food
available ad libitum.
EXPERIMENTAL TREATMENTS
Surgery
The procedures described in Experiment 1 to implant stimulation
electrodes along the left cervical vagus were also followed for this
study. After a one-week period of postoperative recovery, animals
implanted with a stimulation electrode or unoperated controls
were handled for 5min on six consecutive days. On the 7th day of
handling, animals in the VNS groups were stimulated in the han-
dling room with an intensity of either 0.0mA (sham) or 0.4mA
current (10 s on/off, six times) by connecting the vagal electrode
with wires to a current source. The 0.4mA current was selected
because this level of intensity has been shown to improve reten-
tion performance in behavioral learning tasks (Clark et al., 1998,
1999). Animals in the epinephrine injection groups were han-
dled in an identical manner but were given saline, 0.1mg/kg, or
0.5mg/kg epinephrine intraperitoneally. The doses were selected
from those that have been shown to affect plasma epinephrine
levels (McCarty andGold, 1981) andmemory performance (Gold
and van Buskirk, 1975; Williams and McGaugh, 1993; Clayton
and Williams, 2000).
Immunohistochemistry
Ninety minutes after VNS or epinephrine injection, each rat was
deeply anesthetized with 1.3ml/kg pentobarbital (Nembutal) and
then perfused with 100ml 0.01M phosphate buffer saline (PBS)
and then 2000ml fresh 4% paraformaldehyde. The brain was
then removed, post-fixed overnight at 4◦C, stored in 30% sucrose
sliced at the thickness of 50 um and stored in 0.1M PBSwith 0.1%
sodium azide till the processing of immunostaining. Free floating
immunostaining was started with 30min of blocking endogenous
hydrogen peroxidase by 0.3% H2O2 and 0.1% NaN3 in 0.01M
PBS. After rinses, sections were then incubated in solution with
1:1000 goat anti-rat, 1% normal goat serum (NGS), 0.5% Triton
X100, 0.1% NaN3 in 0.01M PBS for two hours at room temper-
ature. After rinses, sections were then incubated in the primary
antibody, 1:50,000 polyclonal rabbit anti-fos (ab5, Oncogene),
with 1% NGS 0.5% Triton X100, 0.1% NaN3 in 0.01M PBS for
48 h at room temperature. After rinses, the sections were incu-
bated in solution with 1:1000 goat anti-rabbit, 1% NGS, 0.5%
Triton X100, 0.1% NaN3 in 0.01M PBS for overnight at room
temperature. After rinses, sections were incubated with 1:500
avidin-biotin-peroxidase complex (ABC kit, Vector Laboratories)
in 0.5% Triton X100 in 0.01M PBS for 3–4 h at room tempera-
ture. After rinses in 0.05M Tris buffer, all sections were simulta-
neously stained in 0.02% nickel-DAB (diaminobenzidine), 0.04%
ammonium chloride sulfate, 0.15% nickel ammonium sulfate,
0.25% 3% H2O2 in Tris buffer for 5–10min till the desired color,
dark purple, developed. The reaction was stopped by rinsing the
sections in 0.01M PBS.
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A second set of sections were used for double immunos-
taining of Fos and DBH. For the DBH immunostaining, the
sections were processed as described above except for the primary
antibody, mouse anti-DBH (Chemicon), for 36–48h (1:30,000
mouse anti-DBH, 1% NGS, 0.5% Triton X100, 0.1% NaN3 in
0.01M PBS), and the DAB staining [0.02% DAB (diaminoben-
zidine), 0.04% ammonium chloride sulfate, 0.25% 3% H2O2 in
Tris buffer] for 5–10min until the desired brown color devel-
oped. After the completion of staining, sections were mounted
on gelatin coated slides, dried overnight, cleaned in 75%, 95%,
100%, 100% ethanol, and Histoclear for 5min in each solution,
and then coverslipped with DPX.
Fos quantification
The number of Fos labeled cells were quantified in six brain
regions, including the shell region of the NAC, CEA, BLA, HIP
(dorsal portion), LC, VLM, and NTS. Additionally, the hypoglos-
sal nucleus and the core region of NAC were selected as control
areas to ensure that Fos was not expressed nonspecifically. Images
were captured using an Olympus CX41 microscope at the mag-
nification of 40X and a Nikon Coolpix 4500 digital camera. The
quantification was conducted using the Scion Image program.
To obtain representative estimates of Fos counts, each image
underwent standard procedures using the Scion Image features
described as follows: (1) defining the boundary of each brain
region with reference to the Brain Atlas (Paxinos and Watson,
1997), (2) background subtraction to equalize the brightness and
contrast, (3) computing Fos positive cells in the defined area
using Scion Image tools. Fos counts in each brain region were
obtained from a fixed number of coronal levels, Figure 5 illus-
trates the specific levels counted in each of the examined brain
regions.
FIGURE 5 | Electrical stimulation of the left vagus nerve significantly
increased Fos-like immunoreactivity in each of the examined brain
regions bilaterally: NAC, CEA, BLA, HIP, LC, VLM and NTS. In addition, the
stimulation also induced an ipsilateral predominance of Fos expression in the
LC and NTS. (∗ , ∗∗ , and ∗∗∗ denotes significant difference between the
compared groups with a p-value less than 0.05, 0.01, and 0.001, respectively).
Photomicrographs of Fos labeling in the NAC (A), HIP (B), CEA (C), BLA (D),
LC (E), VLM (F), and NTS (G) following sham or vagus nerve stimulation.
Scale bar = 200 um. (l.v.: lateral ventricle; a.c.: anterior commisure;
shell: the shell region of the nucleus accumbens; core: the core region
of the nucleus accumbens; 4th v.: the fourth ventricle; a.p.: area
postrema.
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Double labeled (Fos+ and DBH +) cells quantification
The number of double labeled cells was quantified in three brain
regions including LC, VLM, and NTS. An Olympus CX41 micro-
scope was used to visualize and quantify double labeled cells. Two
criteria were developed to designate a given neuron as a dou-
ble labeled cell: (1) a solid, purple/black nucleus and (2) brown
cytoplasm around the nucleus. During quantification, brightness,
and contrast of each image was adjusted to an optimal level. The
observer was blind to the treatment condition.
Statistical analysis
Individual ANOVAs followed by Fisher’s post hoc tests were used
to compare Fos expression between the treatment and control
groups within each brain region following VNS or epinephrine
treatment. Because stimulation of the vagus nerve was unilateral,
Two-Way repeated measure ANOVAs using treatment (sham or
0.4mA) as the between subjects factor and hemispheres (ipsilat-
eral or contralateral to vagal stimulation) as the within subjects
factor were used to analyze data from the vagus nerve treatment.
For epinephrine groups, One-Way ANOVAs were used to deter-
mine differences between the two epinephrine doses and saline.
Statistical significance was achieved when a level of p < 0.05 was
obtained.
RESULTS
Fos INDUCTION IN RESPONSE TO VAGUS NERVE STIMULATION
In the control areas (the hypoglossal nucleus and the NAC core
region), there were no significant differences in the expression of
Fos positive cells between the VNS and sham groups [hypoglossal
nucleus: F(1, 11) = 1.98, p > 0.1; NAC core: F(1, 11) = 3.42, p =
0.09]. Figure 5 shows that electrical stimulation of the left vagus
nerve significantly increased Fos-like immunoreactivity in each of
the following brain regions bilaterally: NAC, CEA, BLA, HIP, LC,
VLM, and NTS. Individual Two-Way ANOVAs using treatment
(sham, 0.4mA) as the between subjects factor and hemisphere
(left vs. right) as the within subjects factor indicated significant
differences in Fos expression between the sham and VNS groups
(NAC: F(1, 11) = 7.29, p < 0.05; CEA: F(1, 11) = 9.36, p < 0.01;
BLA: F(1, 11) = 13.77, p < 0.01; HIP: F(1, 11) = 21.88, p < 0.001;
LC: F(1, 11) = 12.2, p < 0.01; VLM: F(1, 11) = 25.93, p < 0.001;
NTS: F(1, 11) = 10.79, p < 0.01). Post-hoc tests comparing vagal
stimulation and sham groups revealed that stimulation resulted
in significantly more Fos expression within bilateral NAC (Left:
p < 0.05; Right: p < 0.05), CEA (Left: p < 0.05; Right: p < 0.05),
BLA (Left: p < 0.01; Right: p < 0.01), HIP (Left: p < 0.05; Right:
p < 0.001), LC (Left: p < 0.01; Right: p < 0.05), VLM (Left:
p < 0.001; Right: p < 0.01), and NTS (Left: p < 0.05; Right: p <
0.01) compared to sham stimulated animals.
STIMULATION SIDE PREDOMINANCE OF Fos EXPRESSION
Figure 5 also illustrates that electrical stimulation of the left vagus
nerve not only caused bilateral activation in the above men-
tioned brain regions, but also induced a ipsilateral predominance
of Fos expression in the LC and NTS. Within the LC, the Two-
Way ANOVA revealed a hemisphere difference [F(1, 11) = 26.48,
p < 0.001] and interaction between treatment and hemisphere
[F(1, 11) = 9.73, p < 0.01]. Post-hoc tests comparing the two
hemispheres detected a significant predominance of Fos expres-
sion in the left over right hemisphere of the vagus nerve stimu-
lated animals (p < 0.001) but not of the sham controls. Within
the NTS, the Two-Way ANOVA indicated a hemisphere differ-
ence [F(1, 11) = 8.47, p < 0.05]. Post-hoc tests comparing the
two hemispheres showed that both simulation and sham groups
exhibited ipsilateral predominance of Fos expression (0.4mA:
p < 0.05; sham: p < 0.05). No other areas sampled exhibited side
preferences in the expression of Fos.
DOUBLE LABELED (Fos+ /DBH+) CELLS IN LC, VLM, AND NTS
Figure 6 shows that left VNS activated noradrenergic activity in
bilateral LC, bilateral VLM, and ipsilateral NTS. The photomicro-
graphs are shown in Figure 6. Two-Way ANOVAs indicated that
significant more double labeled (Fos+/DBH+) cells were induced
by VNS in the LC [F(1, 11) = 10.09, p < 0.01], VLM [F(1, 11) =
18.44, p < 0.01], and NTS [F(1, 11) = 13.43, p < 0.01]. Post-hoc
tests revealed that VNS induced significant increase of the number
of double labeled cells in the bilateral LC (Left: p < 0.01; Right:
p < 0.05), bilateral VLM (Left: p < 0.01; Right: p < 0.001), and
only left NTS (Left: p < 0.01) following left VNS.
Fos INDUCTION IN THE NTS IN RESPONSE TO EPINEPHRINE
ADMINISTRATION
Injection of 0.1 or 0.5mg/kg epinephrine induced strong Fos
expression along five coronal levels of the NTS. A Two-Way
ANOVA, with treatment (saline, 0.1mg/kg, 0.5mg/kg) as the
between subjects factor and five NTS coronal levels as the within
subjects factor showed that systemic epinephrine injection caused
significant increases in the expression of Fos-like immunoreac-
tivity within the NTS [F(2, 15) = 9.34, p < 0.01]. Post-hoc tests
found that both doses of epinephrine increased Fos expression
significantly across all five levels of the NTS (all p-values < 0.05).
This confirmed the effects of systemic injection of epinephrine
in this study. In the control areas (the hypoglossal nucleus and
the NAC core region), there were no differences in the expression
of Fos positive cells between the epinephrine injected and saline
groups [hypoglossal nucleus: F(2, 15) = 1.26, p > 0.1; NAC core:
F(2, 15) = 1.48, p > 0.1].
Fos INDUCTION IN MEMORY ASSOCIATED AREAS FOLLOWING
EPINEPHRINE ADMINISTRATION
Figure 7 shows that systemic administration of epinephrine
induced significantly more Fos-like immunoreactivity in the fol-
lowing brain regions: NAC, CEA, BLA, HIP, LC, VLM, AP, and
NTS. Because injection was given systemically and no hemi-
sphere difference was found, Fos counts from both hemispheres
were collapsed. Individual ANOVAs indicated significantly
higher Fos expression in response to epinephrine injection
(NAC [F(2, 15) = 7.12, p < 0.01], CEA [F(2, 15) = 10.73, p <
0.01], BLA [F(2, 15) = 16.69, p < 0.001], HIP [F(2, 15) = 5.19,
p < 0.05], LC [F(2, 15) = 7.25, p < 0.01], VLM [F(2, 15) = 10.92,
p < 0.01], and NTS [F(2, 15) = 9.34, p < 0.01]. Post-hoc tests fur-
ther indicated that (1) within the NAC, both doses of epinephrine
caused more Fos-like immunoreactivity than in the saline group
with no significant differences between the two doses (0.1 vs.
saline, p < 0.05; 0.5 vs. saline, p < 0.01), (2) within CEA and
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FIGURE 6 | Left vagus nerve stimulation activated noradrenergic cells in
bilateral LC, bilateral VLM, and ipsilateral NTS. (∗ , ∗∗ , and ∗∗∗ denotes
significant difference between the compared groups with a p-value less than
0.05, 0.01, and 0.001, respectively). Photomicrographs of Fos/DBH labeling in
the LC (A), VLM (B), NTS (C,D) following sham or vagus nerve stimulation.
Scale bar = 200 um. (4th v.: the fourth ventricle).
BLA, both doses of epinephrine induced more Fos expression
than saline. Additionally, 0.5mg/kg caused more Fos expres-
sion than 0.1mg/kg (CEA: 0.5mg/kg vs. 0.1mg/kg, p < 0.05;
0.1mg/kg vs. saline, p < 0.05; 0.5mg/kg vs. saline, p < 0.001;
BLA: 0.5mg/kg vs. 0.1mg/kg, p < 0.01; 0.1mg/kg vs. saline,
p < 0.05; 0.5mg/kg vs. saline, p < 0.001), (3) within HIP, only
0.5mg/kg induced more Fos-like immunoreactivity compared
to saline (0.5mg/kg vs. saline, p < 0.01), (4) within the LC,
VLM, and NTS, both doses induced more Fos-like immunore-
activity compared with the saline group, with no significant
difference between the two doses (LC: 0.5mg/kg vs. saline, p <
0.01; 0.1mg/kg vs. saline, p < 0.05; VLM: 0.5mg/kg vs. saline,
p < 0.01; 0.1mg/kg vs. saline, p < 0.01;NTS: 0.5mg/kg vs. saline,
p < 0.01; 0.1mg/kg vs. saline, p < 0.01).
DOUBLE LABELED (Fos+ /DBH+) CELLS IN LC, VLM, AND NTS
Figure 8 shows that systemic administration of epinephrine acti-
vated noradrenergic cells in the LC, VLM, and NTS. One-
Way ANOVAs indicated that epinephrine injection significantly
increased the number of double labeled cells in the LC [F(2, 15) =
5.28, p < 0.05], VLM [F(2, 15) = 12.29, p < 0.001], and NTS
[F(2, 15) = 33.59, p < 0.0001]. Post-hoc tests showed that both
doses of epinephrine induced more double labeled cells in the
LC (0.1mg/kg vs. saline, p < 0.05; 0.5mg/kg vs. saline, p <
0.05) and VLM (0.1mg/kg vs. saline, p < 0.001; 0.5mg/kg vs.
saline, p < 0.01). However, in the NTS, although both doses of
epinephrine induced significantly more double labeled cells than
saline (0.1mg/kg vs. saline, p < 0.0001; 0.5mg/kg vs. saline, p <
0.0001), the 0.1mg/kg dose induced significantly more double
labeled cells than 0.5mg/kg (0.5mg/kg vs. 0.1mg/kg, p < 0.05).
DOUBLE LABELED CELL PERCENTAGE OF TOTAL Fos+ LABELED
CELLS IN LC, VLM, AND NTS
Figure 9A illustrates that VNS induces noradrenergic activa-
tion that accounts for 44% of the neuronal activity in the
LC, 56% in the VLM, and 8.2% in the NTS. In addition,
0.1mg/kg epinephrine injection induces noradrenergic activation
that accounts for 25% of the neuronal activity in the LC, 39% in
the VLM, and 9.6% in the NTS. Moreover, 24% of the Fos acti-
vation in the LC, 33% in the VLM, and 7.1% in the NTS are
attributed to activated noradrenergic cells induced by 0.5mg/kg
epinephrine.
PERCENTAGE DISTRIBUTION OF DOUBLE LABELED CELLS IN
THE LC, VLM, AND NTS
Figure 9B illustrates that, in the VNS group, out of the total
double labeled cells of the three noradrenergic nuclei, 34% was
contributed by the LC, 55% by the VLM, and 11% by the NTS.
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FIGURE 7 | Systemic injection of epinephrine induced significantly more
Fos-like immunoreactivity in the NAC, CEA, BLA, HIP, LC, VLM, AP, and
NTS. Because injection was given systemically and no hemisphere difference
was found, Fos counts from both hemisphere were collapsed. (∗, ∗∗ , and ∗∗∗
denotes significant difference between the compared groups with a p-value
less than 0.05, 0.01, and 0.001, respectively). Photomicrographs of Fos
labeling in the NAC (A), HIP (B), CEA (C), BLA (D), LC (E), VLM (F),
and NTS (G) following saline, 0.1mg/kg or 0.5mg/kg epinephrine
injection. Scale bar = 200 um (a.c.: anterior commisure; shell: the
shell region of the nucleus accumbens; core: the core region of
the nucleus accumbens; 4th v.: the fourth ventricle; a.p.: area
postrema).
In the epinephrine 0.1mg/kg group, 20% was contributed by the
LC, 47% by the VLM, and 33% by the NTS. In the epinephrine
0.5mg/kg group, 24% was contributed by the LC, 47% by the
VLM, and 29% by the NTS. The numerical summary of the
immunostaining results from the two treatment groups is given
as in Figure 9C.
DISCUSSION
Findings from this series of studies reveal an integral relationship
between the arousal related hormone epinephrine and ascend-
ing fibers of the vagus nerve in influencing memory processing
through interactions with central noradrenergic systems. The
results from Experiment 1 demonstrated that increasing neural
transmission along ascending vagal fibers following learning pro-
duces a significant and long lasting improvement in memory for
emotional experiences. In the present experiment, altering the
contingencies between expected rewards and experienced obser-
vations induced a level of emotional arousal in the Sham or
VNS shifted groups that was reflected in increased latencies to
traverse the length of the maze to receive only 1 as opposed to
the expected 10 food pellets on the day of the Shift. A reduction
in the expected level of reinforcement produces heightened levels
of emotional frustration and changes in neuroendocrine func-
tioning that influence the encoding of memory for these events
(Crespi, 1942; Levine et al., 1972; Goldman et al., 1973). The
vagus nerve plays an important role in this process by convey-
ing to the brain, increased peripheral endocrine and autonomic
activity that transpired as a result of the emotionally frustrating
experience. Consequently, vagal nerve stimulation may produce
beneficial effects on retention performance because increased
vagal output to the brain may represent a natural consequence of
elevated peripheral activity resulting from exposure to environ-
mental events that are salient enough to induce adrenal secretion
of epinephrine.
This view is supported by the finding that retention per-
formance, as reflected by latencies to approach the food cup
and consume the single food pellet reward 7 days following the
Shift in reward magnitude, remained significantly longer than
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FIGURE 8 | Systemic injection of epinephrine activated noradrenergic
cells in the LC, VLM, and NTS. (∗, ∗∗, and ∗∗∗ denotes significant difference
between the compared groups with a p-value less than 0.05, 0.01, and 0.001,
respectively). Photomicrographs of Fos/DBH labeling in the LC (A), VLM (B),
NTS (C,D) following saline or epinephrine injection (0.1mg/kg). Scale
bar = 200 um. (4th v.: the fourth ventricle).
the No-Shift groups. In contrast, the latencies of the Sham-
stimulated groups that also experienced the Shift and reduced
food rewards were no different than those of No-Shift controls
on this delayed retention test. Moreover, the latencies of the VNS
group were also significantly longer on the 7 day delayed test than
the Shifted Sham-stimulated group. These as well as other findings
demonstrate that similar to epinephrine injections, VNS produces
bimodal effects on retention performance. For example, whereas
only moderate doses of epinephrine improve memory, higher
doses of this hormone such as those that result from traumatic
experiences that are not well retained in humans produce amne-
sia (Gold et al., 1977; Izquierdo and McGaugh, 1987). Similarly,
the intensity of current applied to the vagus nerve in the current
study (0.4mA) has been shown to improve memory in one-trial
avoidance tasks in rodents and declarative memory in humans
(i.e., 0.5mA) whereas higher levels of stimulation are known to
producememory impairments (Clark et al., 1998). Thus, the con-
sequences on mnemonic processing in response to graded levels
of vagal input to the brain mirror the dose-dependent inverted-U
actions of peripheral hormones such as epinephrine on mem-
ory formation. Consistent with this view, our findings indicate
that up-regulation of vagal neural activity improves memory
formation as evidenced by the enhanced retention performance
observed in the vagal stimulated groups up to seven days after
learning.
Increasing impulse flow from the vagus nerve to the brain is
an effective method of influencing brain processes that not only
encode memory for experiences that are emotionally arousing
but this treatment has also been shown to improve both recog-
nition and recall performance in humans trained on serial word
lists tasks (Clark et al., 1999; Ghacibeh et al., 2006), increase
non-associative learning in animals (Wang et al., 2005) and
to facilitate attention and alertness in children implanted with
vagal electrodes (Kossoff and Pyzik, 2004). The findings from
the current study corroborate previous reports and extend these
results by revealing that the capacity for vagal input to influ-
ence mnemonic processing is not limited to learning conditions
involving noxious stimuli but activity along this nerve is an essen-
tial component of the processes involved in modulating a broad
range of new emotional learning experiences into long term
memory.
The results from Experiment 2 demonstrated that epinephrine
increases firing discharge along afferent fibers of the vagus nerve
and this change persisted for up to one hour post-injection.
The epinephrine-induced increase in vagal firing was accompa-
nied by significant elevations in extracellular concentrations of
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FIGURE 9 | (A) Percentage of noradrenergic of cell activation. Vagus nerve
stimulation induces noradrenergic activation that accounts for 44% of the
neuronal activity in the LC, 56% in the VLM, and 8.2% in the NTS. In
addition, 0.1mg/kg epinephrine injection induces noradrenergic activation
that accounts for 25% of the neuronal activity in the LC, 39% in the VLM,
and 9.6% in the NTS. Moreover, 24% of the Fos activation in the LC, 33% in
the VLM, and 7.1% in the NTS are attributed to activated noradrenergic cells
induced by 0.5mg/kg epinephrine. (B) Activated noradrenergic cell
distribution. In the vagus nerve stimulation group, out of the total double
labeled cells of the three noradrenergic nuclei, 34% was contributed by the
LC, 55% by the VLM, and 11% by the NTS. In the epinephrine 0.1mg/kg
group, 20% was contributed by the LC, 47% by the VLM, and 33% by the
NTS. In the epinephrine 0.5mg/kg group, 24% was contributed by the LC,
47% by the VLM, and 29% by the NTS. (C) A numerical summary of the
different activation patterns induced by vagus nerve stimulation or systemic
epinephrine injection. The findings indicate that heightened levels of plasma
epinephrine and increased vagal activity are capable of affecting in a similar
fashion, the cellular activity of noradrenergic neurons and its output areas.
Epinephrine injection activates high levels of NTS noradrenergic neurons
whereas the vagus nerve stimulation recruits more LC noradrenergic activity.
As a consequence, epinephrine injected animals exhibited more cell
activation in NTS noradrenergic output areas (CEA, NAC) and vagus nerve
stimulation animals showed more cell activation in LC noradrenergic output
areas (HIP, BLA).
norepinephrine in the basolateral amygdala that remained high
for up to 120min post-injection. Additionally, the results suggest
that the excitatory actions of epinephrine on vagal nerve discharge
are mediated through influences on β-adrenergic receptors. The
β-adrenergic blocker sotalol (2mg/kg) given with epinephrine
was effective in preventing epinephrine related changes in vagal
activity and also blocked the capacity for this hormone to
produce in appreciable changes in amygdala norepinephrine
release. However, peripheral adrenergic blockade with sotalol was
delayed to 60min post-epinephrine injection, only the higher
dose (4mg/kg in the EPI + SOT4 group) was effective in revers-
ing the effects of epinephrine on vagal nerve discharge. But
the counteracting effects were not present immediately. That is,
epinephrine-induced vagal activity and amygdala norepinephrine
levels were not reduced to control levels until 40 and 120min,
respectively post-sotalol injection. Furthermore, in groups where
no increases in vagal discharge were observed, no increases in
norepinephrine release were detected in the basolateral amygdala.
For convenience, these groups (SAL, SAL + SOT4, SOT2 + SAL,
SOT2 + EPI) were referred to as the control groups. Collectively,
our results indicate that changes in vagal discharge and amyg-
dala norepinephrine release are mediated in part by β-adrenergic
receptors in response to the arousal related hormone epinephrine.
Once adrenergic activity is enhanced by epinephrine, it requires a
higher dose of an adrenergic antagonist to counteract epinephrine
effects.
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EPINEPHRINE vs. SALINE
Findings from the current study show that a single injection of
the hormone at a dose of 0.3mg/kg significantly increased neural
impulses propagated along ascending vagal fibers for approxi-
mately 50min. The magnitude of the increase peaked at 30%
above baseline 30min post-epinephrine injection. The concomi-
tant microdialysis data show that peripheral epinephrine elevates
noradrenergic output in the basolateral amygdala in a pattern
that is similar to the changes this hormone induces initially
on the firing rates of vagal fibers. Unlike vagal activity how-
ever, amygdala norepinephrine release induced by epinephrine
remained elevated for the entire collection period (i.e., 180min).
Norepinephrine levels were 44% higher than baseline at 40min
post injection, 77% higher at 180min post injection indicat-
ing an increasing elevation of central noradrenergic activity in
response to peripheral epinephrine. Consequently, we hypothe-
size that the role of ascending vagal fibers may play an integral
role in initiating, as opposed to maintaining brain noradrenergic
activation in response to increased peripheral adrenergic activ-
ity. Therefore, central noradrenergic activation, induced by sys-
temic epinephrine injection may be initiated by increased neural
impulses carried by ascending vagal fibers and then maintained
by other mechanisms.
Neural activity propagated along vagal afferent fibers may
recruit additional mechanisms that affect long-term changes in
CNS functioning. In fact, cAMP has been reported to accu-
mulate in the vagus nerve following incubation in a medium
containing epinephrine (Roch and Salamin, 1977). The change
in vagal concentrations of cAMP has been reported to increase
as much as 10–50-fold following incubation in solutions con-
taining the β adrenergic agonist isopreteronol (Schreurs et al.,
1986). Given the importance of cAMP as an important sec-
ond messenger essential for ligand gated neurotransmission, the
accumulated cAMP molecules might be trafficked to areas that
undergo cAMP-PKA-dependent transmission, such as the cen-
tral nervous system. It is known that vagal afferents influence the
level of cAMP in central sites of termination such as the NTS,
which then determine the state of activation in post-synaptic
NTS neurons (Browning and Travagli, 2006). Noradrenergic cells
are one major type of post-synaptic NTS neurons. Given the
fact that noradrenergic neurotransmission is mostly cAMP PKA-
dependent, accumulated cAMP in the vagus nerve following
epinephrine treatment might be utilized to promote noradrener-
gic activity in the NTS. In fact, in severely stressful conditions that
are known to enhance peripheral adrenergic activity, NTS neu-
rons are up-regulated with PKA, Fos, and tyrosine hydroxylase
immunoreactivity (Benavides et al., 2005). This is consistent with
the finding that noradrenergic neurons are activated in response
to increased vagal activity or peripheral adrenergic activity. With
the activation of NTS noradrenergic neurons, norepinephrine
release in the basolateral amygdala can then be initiated and
maintained.
Findings emerging from the final study reveal that systemic
epinephrine injection and VNS induce similar patterns of neu-
ronal activation within brain regions associated with memory.
Our findings indicate that treatments that raise circulating lev-
els of epinephrine in the periphery or increase discharge along
ascending fibers of the vagus nerve produce similar changes in
the expression of Fos proteins in noradrenergic neurons in the
NTS, LC, VLM, and their areas of termination. The results show
that central noradrenergic nuclei represent a primary target of
peripheral systems that are engaged by exposure to emotionally
arousing events. In turn, activation of noradrenergic release in
each of the limbic circuits identified in this study constitutes areas
wherein the beneficial effects of heightened levels of arousal in the
periphery influence the effective storage of events into memory.
When comparing the number of Fos expressing cells observed
in response to either vagal stimulation or epinephrine injec-
tions, the two doses of epinephrine recruited nearly three times
as many Fos neurons as that produced by vagal stimulation
(EPI 0.1mg/kg: 1107 ± 125; EPI 0.5mg/kg: 1128 ± 264; VNS:
388.58 ± 58). The difference in treatments most likely accounts
for this observation. For example, in contrast to the unilat-
eral stimulation of the vagus nerve, both vagal nerves are most
likely activated in response to the systemic epinephrine injections
and the observed effects may reflect the central consequences of
increasing discharge along both vagi.
Even though NTS neurons were activated to a different degree
by the separate treatments, the patterns of increased activation
within other more rostral structures were uniformly bilateral.
Systemic injection of epinephrine produced equivalent activa-
tion in both hemispheres within all of the examined areas, i.e.,
NTS, VLM, LC, BLA, CEA, HIP, and NAC. Similar findings were
observed after vagal stimulation, with the exception of a clear
ipsilateral predominance of Fos expression in the NTS and LC.
Consistent with previous studies (Gieroba and Blessing, 1994;
Osharina et al., 2006), this observation suggests that the prop-
agation of ascending information from the vagus bifurcates at
the level of the NTS and LC. Vagal afferents first decussate at
the spinal trigeminal tract before entering the NTS (Kalia and
Mesulam, 1980; Ranson et al., 1993; Norgren and Smith, 1994).
NTS neurons then project to a wide range of medullary and
pontine areas bilaterally (Otake et al., 1992). Based upon these
observations, VLMprojecting neurons in the NTS send out nearly
equivalent innervations to both hemispheres whereas LC pro-
jecting neurons show an ipsilateral predominance. LC neurons
subsequently project to several forebrain areas bilaterally with an
ipsilateral predominance (Jones and Moore, 1977; Espana and
Berridge, 2006).
Animal studies that investigated the effects of VNS on fore-
brain areas are relatively sparse. According to currently available
evidence, noradrenergic output is up-regulated in the amygdala
(Hassert et al., 2004), hippocampus, and cortex (Roosevelt et al.,
2006). Additionally, the Roosevelt et al. study (2006) reported
a bilateral activation pattern following VNS at an intensity of
0.5mA in the hippocampus, or of 1.0mA in both the hip-
pocampus and cortex. These findings are consistent with the Fos
activation patterns obtained in our study. That is, we observed
equivalent increases in both hemispheres following VNS at an
intensity of 0.4mA in noradrenergic output areas, including
NAC, CEA, BLA, and HIP.
The findings from neuroimaging studies that investigated
the clinical therapeutic effects of VNS in treating epilepsy
and depression are generally congruent with our findings.
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Significant increases in cerebral blood flow after acute left vagal
stimulation was noted bilaterally in the hippocampus, amygdala,
orbitofrontal gyri, cingulate, thalami, hypothalami, and the ante-
rior insula (Henry et al., 1998). However, changes observed after
vagal stimulation in a fMRI study of patients with intractable
depression involved increased blood oxygenation level in bilat-
eral orbitofrontal and parieto-occipital cortex, left temporal cor-
tex, amygdala, and the hypothalamus (Bohning et al., 2001). In
patients with refractory epilepsy, VNS-induced activation was
detected in bilateral thalamus, insular cortices, postcentral gyri
and inferomedial occipital gyri, left basal ganglia, and right poste-
rior superior temporal gyrus (Narayanan et al., 2002). Although
side predominance was observed in some of the neuroimaging
studies, neuroimaging evidence is still in agreement with our
findings that VNS induces equivalently bilateral activation in
brain areas that are secondary to the stimulation site, i.e., limbic
areas in our study.
NORADRENERGIC ACTIVATION PATTERNS
Although the activation patterns (indicated by Fos data) within
the lower brain regions appear similar following the two treat-
ments, double labeling data found that each of the noradrenergic
nuclei may have different roles in enhancing central noradrener-
gic activity. That is, VNS induces a higher percentage of nora-
drenergic activation in the LC (44%) and VLM (56%) than
epinephrine injection whereas epinephrine injection recruits a
higher percentage (9.6% by 0.1mg/kg) of noradrenergic acti-
vation in the NTS. The contribution of each nucleus is best
shown by the distribution of activated noradrenergic (double
labeled) neurons within the three noradrenergic regions. Results
indicate that the LC noradrenergic neurons are more involved
in the VNS activation whereas the NTS is more important in
the epinephrine injection activation. VLM A1 cells, however,
account for nearly half of the noradrenergic activation induced
by either treatment, with a higher predominance following
VNS.
In conclusion, the collective findings demonstrate an integral
role of epinephrine and the vagus nerve in influencing cen-
tral noradrenergic systems ascribed a role in processing memory
for emotionally arousing experiences. The findings also illus-
trate how interactions between these two peripheral endocrine
and autonomic systems serve an important function in ele-
vating and maintaining heightened levels of central activity in
response to emotionally salient events. This comprehensive anal-
ysis of vagal nerve functioning in memory, in regulating nore-
pinephrine output in the amygdala and in influence activity in
norepinephrine containing cell bodies in the CNS reveals the
important contribution of this nerve in facilitating “peripheral
to central” communication during critical states of emotional
arousal.
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